Lung congestion
Searched over 200M research papers for "lung congestion"
Summary
10 papers analyzed
These studies suggest lung congestion can be detected and monitored using chest ultrasound and lung ultrasonography, is associated with worse outcomes in heart failure and hemodialysis patients, and may be influenced by nerve stimulation and potential treatments like TRPV4 blockade.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Lung Congestion: Mechanisms, Detection, and Prognostic Value
Mechanisms of Lung Congestion in Heart Failure
Hemodynamic Basis in HFpEF
Lung congestion, particularly during exercise, is a significant issue for patients with heart failure with preserved ejection fraction (HFpEF). Research indicates that over half of stable outpatients with HFpEF experience increases in extravascular lung water (EVLW) during submaximal exercise. This congestion is closely linked to elevated pulmonary capillary wedge pressure (PCWP) and right atrial (RA) pressures, as well as impairments in right ventricular-pulmonary artery (RV-PA) coupling. These factors collectively contribute to fluid filtration into the lungs, leading to congestion.
Pulmonary Capillary Permeability
Targeting pulmonary capillary permeability has emerged as a novel approach to managing lung congestion in heart failure. The transient receptor potential vanilloid 4 (TRPV4) channel, which regulates fluid transit across the pulmonary capillary interface, represents a potential therapeutic target. Blocking TRPV4 could reduce lung water independently of pulmonary capillary hypertension, offering a new avenue for treatment.
Detection of Lung Congestion
Lung Ultrasound (LUS)
Lung ultrasound (LUS) has proven to be a valuable tool for detecting and monitoring pulmonary congestion. In patients with acute heart failure (AHF), LUS can quantify B-lines, which are indicative of pulmonary congestion. Studies have shown that a higher number of B-lines at admission and discharge correlates with an increased risk of adverse events, including heart failure hospitalization and all-cause mortality . Additionally, LUS can detect subclinical pulmonary congestion in ambulatory heart failure patients, providing prognostic information that is not captured by traditional clinical examination or chest radiography.
Chest X-ray (CXR)
While chest X-ray (CXR) is widely used, its prognostic value in quantifying lung congestion remains uncertain. However, recent studies suggest that a higher congestion score index (CSI) on admission CXR is associated with longer hospital stays and a higher risk of adverse outcomes in patients with worsening heart failure (WHF). Combining CSI with estimated plasma volume status (ePVS) can improve risk stratification for these patients.
Lung Ultrasound in Acute Kidney Injury (AKI)
Lung congestion is also a complication in patients with acute kidney injury (AKI). Lung ultrasound has shown potential in detecting lung congestion at a pre-clinical stage in AKI patients, often identifying moderate to severe congestion even in asymptomatic individuals. This early detection could be crucial for guiding treatment and improving clinical outcomes.
Prognostic Value of Lung Congestion
Heart Failure and Mortality
Pulmonary congestion detected by LUS is a strong predictor of adverse outcomes in heart failure patients. In both acute and chronic settings, a higher number of B-lines is associated with increased risks of hospitalization and mortality. This relationship persists even after adjusting for other clinical variables, highlighting the importance of LUS in the prognostic assessment of heart failure patients .
End-Stage Renal Disease (ESRD)
In patients with end-stage renal disease (ESRD) undergoing hemodialysis, lung congestion is prevalent and often asymptomatic. The presence of moderate to severe lung congestion, as measured by B-lines on ultrasound, significantly increases the risk of death and cardiac events. This underscores the need for regular monitoring and early intervention in this high-risk population.
Conclusion
Lung congestion is a critical factor in the management of heart failure and other conditions like acute kidney injury and end-stage renal disease. Advances in detection methods, particularly lung ultrasound, have improved our ability to identify and quantify pulmonary congestion, providing valuable prognostic information. Understanding the hemodynamic mechanisms and exploring new therapeutic targets, such as TRPV4, could further enhance treatment strategies and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic
